As the “one-size-fits-all” nutritional model becomes less relevant, consumer interest in personalized nutrition and ‘taking back control’ is growing, but the past 15 years are littered with harsh lessons. So, why are today’s companies better positioned...
By analysing the long-lasting commitments and acquisition activity of major companies Dr Matthew Jones at CPL Business Consultants uses the Red Queen theory to develop an understanding of their corporate mind-set and appetite for acquisitions and partnerships...
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.
Interview: Samy Jandali, VP Nutrition & Health, North America, BASF
One year on from the $3.1 billion acquisition of Cognis, Samy Jandali, VP of nutrition and health North America for BASF, told Stephen Daniells why he is impressed with the progress of the integration and why we can expect more M&A in the nutrition...
Enhanced waters, carbonated soft drinks, still beverages, dairy products, instant beverages, nutrition bars and baked goods are being targeted by BASF as part of an intensified nutrition push in the US.
The divestiture of a joint venture between BASF and Fortitech will
have no impact on customers, said Fortitech, which confirmed that
it will continue to make its nutrient premixes with the same
Germany chemicals group BASF is implementing a new measure to
combat price pressure on its vitamin businesses in the long-term,
by combining its human and animal nutrition resources under the
banner of a new nutrition unit within...
BASF's fine chemicals division reported a huge rise in operating
profits in second quarter 2006 - no thanks to vitamins. Rather,
credit is given to a swift trade in aroma chemicals and gains from
contract manufacturing and personal...
BASF's fine chemicals division is bolstered by higher sales volume
of aroma chemicals and vitamins A and E for animal nutrition, but
the pressure over vitamin C and lysine has not abated, dragging
down the division's profitability.
BASF and Daiichi, two of the companies involved in the 1990s
vitamin cartel, have had their fines significantly reduced by a
European court, which ruled that the Commission made errors when
calculating the fines.
German chemicals group BASF said it performed well last year and is
confident of further growth in 2002 despite difficult trading
conditions. All of the company's divisions performed well, despite
high raw material prices and...